Press Release

Medtronic Supports Boston Area Retreat & Refresh Stroke Camp for Stroke Survivors and Caregivers

Medtronic, Inc.

Brigham and Women's Hospital, Massachusetts General Hospital and Spaulding Rehabilitation Hospital Bring Stroke Camp to Area Stroke Survivors and Caregivers

DUBLIN - August 14, 2015 - Three leading Boston-area hospitals - Brigham and Women's Hospital, Massachusetts General Hospital and Spaulding Rehabilitation Hospital - have teamed up to bring stroke victims the Retreat & Refresh Stroke Camp (Stroke Camp), sponsored by Medtronic. Stroke Camp, a three-day retreat for stroke survivors, caregivers and family members, will be held Aug. 14-16 in Contoocook, New Hampshire. This is the third of four rehabilitative camps this year across the United States, in partnership with local area hospitals and Stroke Camp founder Marylee Nunley.

"Stroke affects not only patients, but caregivers, families, communities and friends," said Dr. Ali Aziz-Sultan, the chief of vascular/endovascular neurosurgery at Brigham and Women's Hospital. "Stroke Camp helps provide a getaway where survivors, caregivers and families can share the daily triumphs and challenges they face every day. We're proud to be a part of a weekend where these individuals are given the opportunity to relax and share, building relationships that will last a lifetime."
Stroke Camp offers a restorative experience for stroke survivors and their caregivers, most often a spouse or sibling, in an engaging, medically-supervised setting. With the help of volunteers, participants are provided an opportunity to relax and enjoy recreational activities reminiscent of summer camp.

Medtronic has sponsored Stroke Camp since 2014 and is committed to helping fight stroke. In addition to supporting endeavors such as Stroke Camp, Medtronic is committed to bringing the best medical technology to fight this disease to market. Recently, stent retrievers such as its Solitaire(TM) stent retriever device, which helps to immediately restore blood flow and remove blood clots causing stroke, were included in the American Heart Association/American Stroke Association (AHA/ASA) new stroke treatment guidelines that recommend the use of this technology in conjunction with the current standard of care, IV-tPA, for eligible patients.

"The patients, caregivers and physicians, like those involved in each Stroke Camp, inspire our work. Until we can eliminate the burden of stroke, we are pleased to support the therapeutic benefits of this well-deserved retreat," said Brett Wall, president of the Neurovascular business, which is part of the Restorative Therapies Group at Medtronic.

Stroke is caused by a blood clot that blocks a blood vessel in the brain. It is the fifth leading cause of death in the U.S., and the leading cause of long-term disability.i If a person is exhibiting signs of numbness or weakness in the face, arm or leg, or having trouble speaking, seeing or walking, call 9-1-1 and seek treatment immediately.

The grant for the Retreat & Refresh Stroke Camp is funded by Medtronic's community outreach program.

About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is the global leader in medical technology - alleviating pain, restoring health and extending life for millions of people around the world.

About Retreat & Refresh Stroke Camp(TM)
Founded in 2004, Retreat & Refresh Stroke Camp(TM) offers weekend retreats for stroke survivors and their caregivers. Stroke Camp became a non-profit organization in 2007 and has since developed a national network of camps. The National Stroke Association awarded RRSC the Raising Awareness in Stroke Excellence (RAISE) Group Award in October 2013. In addition to the multitude of camps, Stroke Camp has created and distributed an educational DVD titled "You've had a Stroke, Now What?". Stroke Camp is dedicated to providing community stroke education through Strike Out Stroke baseball events, MEGABrain exhibits, community chimes choirs, and fifth grade education. For more information, visit http://www.strokecamp.org or call 309-688-5450.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

-end-

 

Contacts:
David T. Young
Public Relations
+1-508-452-1644

Ryan Weispfenning
Investor Relations
+1-763-505-4626


HUG#1945613
X